{"filing":{"accession_number":"0001193125-26-278642","cik":"0001840229","ticker":"INKT","company_name":"MiNK Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"inkt-20260617.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840229/000119312526278642/inkt-20260617.htm"},"events":[{"id":13064,"run_id":11592,"accession_number":"0001193125-26-278642","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 discloses the results of MiNK Therapeutics' Annual Meeting of Stockholders held on June 17, 2026, including the election of three Class II Directors (Garo Armen, Barbara Ryan, and John Holcomb) and ratification of KPMG LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.","company_name":"MiNK Therapeutics, Inc.","ticker":"INKT","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10105,"accession_number":"0001193125-26-278642","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of MiNK Therapeutics' Annual Meeting of Stockholders held on June 17, 2026, including the election of three Class II Directors (Garo Armen, Barbara Ryan, and John Holcomb) and ratification of KPMG LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T14:10:37.940744+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10105,"accession_number":"0001193125-26-278642","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of MiNK Therapeutics' Annual Meeting of Stockholders held on June 17, 2026, including the election of three Class II Directors (Garo Armen, Barbara Ryan, and John Holcomb) and ratification of KPMG LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T14:10:37.940744+00:00","company_name":"MiNK Therapeutics, Inc.","ticker":"INKT","filing_date":"2026-06-23"}]}